Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 9.
NOVAVAX Completes First Stage Of Enrollment In Pivotal H1N1 Influenza Vaccine Study In The Country Of Mexico
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novavax, Inc. (Nasdaq: NVAX
) announced today that enrollment has been completed in the first stage of a two-stage clinical study of its novel 2009 H1N1 virus-like-particle (VLP) pandemic influenza unadjuvanted vaccine in the country of Mexico.
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies Of Apoptone (HE3235) At AACR Molecular Targets And Cancer Therapeutics ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH
), today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC).
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Today's Opinions And EditorialsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Half Done On Health Reform The Washington Post Unless you find more realistic ways of paying for the promises included in the bill, you are simply setting up the public for more frustration -- and yourselves for a political backlash (David Broder, 11/13).
Source: Pharma Industry News From Medical News Today - November 16, 2009 Category: Pharmaceuticals Tags: Health Insurance / Medical Insurance Source Type: news
ThromboGenics And BioInvent Complete Phase I Patient Trial Of Anti-PlGF Cancer Therapeutic TB-403 In Patients With Advanced Solid TumoursEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (OMXS: BINV) today announced positive results from a Phase I trial of their novel anti-cancer monoclonal antibody TB-403 in patients with advanced solid tumours.
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Biomodels Scientists Report Development Of A Novel Model For Cancer Treatment-Related FatigueEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists at Biomodels
have successfully developed the first model that accurately duplicates human cancer treatment-related fatigue
(CTRF).
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
GSK And Nabi Announce Agreement For NicVAX, A Vaccine For Nicotine AddictionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) recently announcedan exclusive worldwide option and licensing agreement for a nicotine conjugate candidate vaccine (NicVAX), an investigational vaccine for the treatment of nicotine addiction and the prevention of smoking relapse, as well as for the development of a second generation nicotine vaccine.
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Abbott Announces Positive Three-Year Data On Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) today announced three-year data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries.
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
FDA Approves Additional Vaccine For 2009 H1N1 Influenza VirusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.
Source: Pharmaceutical Online News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Glenmark Generics settles litigation with MedicisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Glenmark Generics Inc, the US unit of Glenmark Generics Ltd , on Monday said that it has settled all pending litigation with Medicis Pharmaceutical Corp relating to patent actions regarding Fluocinonide.
Source: The Economic Times Healthcare and Biotech News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Abbott.com - November 16, 2009 Category: Pharmaceuticals Source Type: organizations
Bristol-Myers to Split Off MeadEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bristol-Myers Squibb aid it is moving to split off its nutritionals business in a deal valued at up to about $6.5 billion, an unusual bid to focus the drug maker on its core medicine business.
Source: WSJ.com: Health - November 16, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Bristol-Myers to Split Off Mead Johnson Nutrition Co.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bristol-Myers Squibb aid it is moving to split off its nutritionals business in a deal valued at up to about $6.5 billion, an unusual bid to focus the drug maker on its core medicine business.
Source: WSJ.com: Health - November 16, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Data Reveal Cardiac Death's TollEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers said men at age 40 in the U.S. have a one-in-eight chance of suffering sudden cardiac death over the rest of their lives.
Source: WSJ.com: Health - November 16, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Animascope to Present its R&D Imaging Services at BIOTECH 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Animascope recently attended the BIO-Europe 2009 partnering event, which was held in Vienna, Austria, and the company now plans to attend the BIOTECH 2009 biotechnology fair, which will take place 25-27 November in Milano, Italy.
Animascope is dedicated to providing non-invasive biomedical imaging services, and regularly attends industry events in order to increase its presence in the sector and stay up to date with the latest developments in the biotechnology and biopharmaceutical fields.
Animascope invites you to join them at BIOTECH 2009, where you will be able to find out more about ...
Source: Drug Development Technology - November 16, 2009 Category: Pharmaceuticals Source Type: info
Sanofi-aventis and Regeneron expand strategic Antibody CollaborationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
Source: World Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Novartis launches Prevacid® 24 HR over-the-counterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novartis announced the availability of Prevacid®24HR (lansoprazole delayed-release capsules 15 mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn. Prevacid®24HR received US Food and Drug Administration (FDA) approval in May 2009.
Source: World Pharma News - November 16, 2009 Category: Pharmaceuticals Source Type: news
Amgen to Present at Lazard Capital Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
THOUSAND OAKS, Calif., Nov. 16 /PRNewswire-FirstCall/—Amgen (Nasdaq: AMGN) will participate in the Lazard Capital Healthcare Conference on Wednesday, Nov. 18, 2009, at the St. Regis Hotel in New York City, beginning at 9:30 a.m. Eastern Time. Arvind Sood, vice president, Investor Relations at Amgen, will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, www.amgen.com, under Investors.
Source: Amgen News Service - November 16, 2009 Category: Pharmaceuticals Authors: pmannle at amgen.com Tags: Press Releases Source Type: organizations
Another Vytorin Mess For MerckEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new study, though flawed, inflicts more damage on the company's Zetia and Vytorin cholesterol pills.
Source: Forbes.com Healthcare News - November 15, 2009 Category: Pharmaceuticals Source Type: news
GSK plans to cut drug production wasteEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The UK-based pharmaceutical group has set a target to cut by two-thirds the waste generated by medicines production
Source: FT.com - Drugs and Healthcare - November 15, 2009 Category: Pharmaceuticals Source Type: news
Merck Expresses Confidence In The Efficacy And Safety Profiles Of ZETIA (ezetimibe) And VYTORIN (ezetimibe/simvastatin) As Effective Medicines For Managing Elevated CholesterolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At the American Heart Association meeting recently, Merck & Co., Inc. said it is confident in the safety and efficacy profiles of ZETIA (ezetimibe) and VYTORIN (ezetimibe/simvastatin), and issued the following comment in response to misinterpretation of results from a small 200-patient imaging study called ARBITER 6.
Source: Pharmaceutical Online News - November 15, 2009 Category: Pharmaceuticals Source Type: news
Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Abbott.com - November 15, 2009 Category: Pharmaceuticals Source Type: organizations
Abbott Statement On ARBITER 6 - HALTS Results And Abbott's Niaspan (Niacin Extended-Release)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Results from the investigator-initiated ARBITER 6 - HALTS study showed patients at high cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of therapy with Abbott's Niaspan® (niacin extended-release tablets) plus a statin, the study's primary endpoint.
Source: Pharmaceutical Online News - November 15, 2009 Category: Pharmaceuticals Source Type: news
Genzyme Issues Letters to U.S. Healthcare ProvidersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 13, 2009 -
Genzyme Corp. (Nasdaq: GENZ) announced today that it has issued
letters to U.S. healthcare providers regarding its enzyme
replacement products Cerezyme® (imiglucerase for
injection),...
Source: Drugs.com - Pharma News - November 14, 2009 Category: Pharmaceuticals Source Type: news
Merck Strengthens Its Commitment to Advancing Cardiovascular Health CareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Nov 14, 2009 -
Following the completion of its merger with Schering-Plough, Merck
today confirms and underscores its commitment to marketing and
developing cardiovascular medicines for a range of...
Source: Drugs.com - Pharma News - November 14, 2009 Category: Pharmaceuticals Source Type: news
DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and AdvancesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Drug Information Association (DIA), in cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best Practices on December 8, 2009 in Washington, DC. (PRWeb Nov 14, 2009)
Read the full story at http://www.prweb.com/releases/dia_phrma/dried-blood-sampling/prweb3200984.htm
Source: PRWeb: Medical Pharmaceuticals - November 14, 2009 Category: Pharmaceuticals Source Type: news
Caffeine, Alcohol Drinks TargetedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA said it will pull drinks containing caffeine and alcohol off the market unless manufacturers can prove the beverages are safe to drink.
Source: WSJ.com: Health - November 14, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
War-Zone Counselors in Short SupplyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Army has a shortage of mental-health workers in Afghanistan, where morale has fallen among soldiers charged with fighting the resurgent Taliban, according to a new survey.
Source: WSJ.com: Health - November 14, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Caffeine, Alcohol Drinks TargetedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA said it will pull drinks containing caffeine and alcohol off the market unless manufacturers can prove the beverages are safe to drink.
Source: WSJ.com: Health - November 14, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
FDA to Pull Caffeinated Alcoholic DrinksEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA said it will pull drinks containing caffeine and alcohol off the market unless manufacturers can prove the beverages are safe to drink.
Source: WSJ.com: Health - November 14, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
War-Zone Counselors in Short SupplyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Army has a shortage of mental-health workers in Afghanistan, where morale has fallen among soldiers charged with fighting the resurgent Taliban, according to a new survey.
Source: WSJ.com: Health - November 14, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Grandma knows best when it comes to drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A small cluster of British drug companies is marketing drugs that are decades old, relying on consumers' affection for products that they probably first saw in their grandparents' medicine chest
Source: FT.com - Drugs and Healthcare - November 14, 2009 Category: Pharmaceuticals Source Type: news
Making the Case for Continuous ProcessingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Other industries show what is possible in pharma, aided by open control systems.
Source: PharmaManufacturing.com - November 13, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
FDA to Look at New Type of Flu VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An FDA panel will meet next week to consider a new type of vaccine that's made without relying on old technology that employs chicken eggs to grow viruses used for flu shots.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Cleviprex Results Reported From Study in Patients With Intracerebral HemorrhageEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ACCELERATE Data Presented at the
Annual Meeting of the Neurocritical Care
Society
PARSIPPANY, NJ, Nov 12, 2009 (MARKETWIRE via
COMTEX) -- First reported interim data from the Evaluation of
patients with acute hypertension and intracerebral...
Source: Drugs.com - Clinical Trials - November 13, 2009 Category: Pharmaceuticals Source Type: clinical trials
FDA Finds Bits of Steel, Rubber in Genzyme DrugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated
Press (November 13, 2009)
WASHINGTON-Federal health regulators have found tiny particles
of trash in drugs made by Genzyme, the second time this year the
biotechnology company has been cited for contamination issues.
The Food and...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Lilly Names New Research HeadEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Eli Lilly named the former head of AstraZeneca's drug-development to lead its research and development operation.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Swiss OK Novartis Swine Flu Vaccine From CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 13, 2009)
BASEL, Switzerland (AP)--Swiss pharmaceutical company
Novartis AG said Friday it has
received regulatory approval in Switzerland for a swine flu vaccine
produced using cell cultures instead of egg-based...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Google, Yahoo Call for Expanded Online Drug AdsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated
Press (November 12, 2009)
WASHINGTON (AP) -- Google, Yahoo and other Web companies joined
the pharmaceutical industry Thursday in urging U.S. government
regulators to make it easier to pitch drugs in online
advertisements.
The Food...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Cephalon, Barr Settle Fentora DisputeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 12, 2009)
NEW YORK (AP) -- Cephalon Inc. will give Barr Pharmaceuticals
Inc. a license to sell a generic version of the pain drug Fentora
in 2018 as part of a patent lawsuit settlement, according to a
Securities and...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his SuccessorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIANAPOLIS, Nov. 13 (HSMN NewsFeed) -- Eli Lilly and Company (NYSE: LLY ) announced today that Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire from Lilly effective February... Biopharmaceuticals, PersonnelEli Lilly
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FARMINGDALE, N.Y., Nov. 13 (HSMN NewsFeed) -- Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has e... Devices, Surgery, DistributionMisonix, Xenith, SonaStar, BoneScalpel, SonicOne, ultrasonic aspirator
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Noted clinical experts detail recent developments at the annual ASTRO meeting in Chicago
PALO ALTO, Calif., Nov. 13 (HSMN NewsFeed) -- Clinical studies suggest that advanced treatments like intensity-modulated radiotherapy (IMRT) and image-guided radi... Devices, OncologyVarian Medical Systems, image-guided radiotherapy, IGRT, radiotherapy
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic InsufficiencyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PHILADELPHIA, PA - (HSMN NewsFeed) - Eurand N.V. (NASDAQ:EURX ), a global specialty pharmaceutical company, today announced data from a Phase II/III clinical study demonstrating that ZENPEP(TM) (pancrelipase) Delayed-Release Capsules significantly improves... BiopharmaceuticalsEurand, ZENPEP, pancrelipase, exocrine pancreatic insufficiency, pancreatitis
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Google Helps You Find A Flu ShotEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From TechwebNews.com (November 12, 2009)
(TechwebNews.com ) - Google Flu Shot Finder With flu vaccines in
short supply, Google is stepping up to help people find places to
get immunized by launching a flu shot finder application for Google
Maps.
Flu...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
